Stokes Bio

The company also said it expects continued growth in this area due in part to the introduction later this year of microfluidics-based PCR technology obtained through last year's acquisition of Stokes Bio.

Startups QuantaLife and Inostics join more established outfits RainDance Technologies and Life Technologies in exploring the digital PCR market, but all players will need to negotiate what is sure to be a complex intellectual property landscape.

Digital PCR may be on the verge of becoming nearly as ubiquitous as its predecessor, quantitative real-time PCR, thanks to the integration of empowering nanoscale and microfluidic technologies.

Life Tech officials said that Stokes Bio's microfluidics-based technology platform will enable high-throughput, PCR-based genetic analyses for a variety of applications, particularly in the area of agricultural biology.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.